Clin Case Rep Int | Volume 4, Issue 1 | Mini Review | Open Access

Clinical Efficacy and Safety of Edaravone a New Molecule as a Ray of Hope for Motor Neuron Disease (An Incurable Illness) a Mini Review

Omar Farooq^* and Neha Sharma

Department of Medicine, GMC Srinagar, India

^*Correspondance to: Omar Farooq 

Abstract

The etiology of Amyotrophic Lateral Sclerosis (ALS) is unknown. Oxidative stress may be one of the major mechanisms involved. In vitro and in vivo data of edaravone suggest that it may possess broad free radical scavenging activity and protect neurons, glia, and vascular endothelial cells against oxidative stress. This paper describes and reviews data pertinent to the potential mechanism of action of edaravone, and reviews the development history of edaravone for the treatment of ALS.

Citation:

Farooq O, Sharma N. Clinical Efficacy and Safety of Edaravone a New Molecule as a Ray of Hope for Motor Neuron Disease (An Incurable Illness) a Mini Review. Clin Case Rep Int. 2020; 4: 1157.